产品中心 抗体 其他一抗

所有图片(1/12)

COXIV Recombinant Mouse mAb (S-5528)

Cytochrome c oxidase subunit 4 isoform 1,mitochondrial,Cytochrome c oxidase polypeptide IV,Cytochrome c oxidase subunit IV isoform 1 (COX IV-1),COX4,COX4I1

价格 600.00 1-2周
货号 S0B60250
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    COXIV
  • 分子别名

    Cytochrome c oxidase subunit 4 isoform 1, mitochondrial; Cytochrome c oxidase polypeptide IV; Cytochrome c oxidase subunit IV isoform 1 (COX IV-1); COX4; COX4I1
  • 细胞定位

    Mitochondrion
  • Accession

    P13073
  • 克隆号

    S-5528
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1
  • 反应种属 ?

    Hu, Mk
  • 阳性样本

    HeLa, HepG2, A431, Jurkat, MCF7, LnCap, COS-7
  • 纯化方式

    Protein G
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    IHC-P ?

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:5000-1:50000 Hu, Mk
    IHC-P 1:2000 Hu
背景介绍
  • COXIV is a key subunit of cytochrome c oxidase (Complex IV), the final enzyme complex in the mitochondrial respiratory chain. This protein consists of approximately 160 amino acids, containing an N-terminal mitochondrial targeting sequence and multiple α-helical transmembrane domains, and is primarily anchored in the inner mitochondrial membrane. COXIV serves dual important functions—structural and regulatory: on one hand, it provides structural support for the core catalytic subunits (COX I and COX II) of Complex IV, assisting in the assembly and stability of the entire enzyme complex; on the other hand, it senses the cellular energy state through an ATP/ADP binding site, thereby allosterically regulating the catalytic activity of Complex IV to match the efficiency of electron transfer in the respiratory chain with ATP synthesis demands. Furthermore, COXIV expression levels vary across different tissues (such as the liver-type COXIV-1 and lung-type COXIV-2 isoforms), and its expression is regulated by transcription factors such as hypoxia-inducible factor HIF-1α, playing a role in cellular responses to hypoxic stress and metabolic reprogramming. At the pathological level, mutations or aberrant expression of COXIV are closely associated with various mitochondrial diseases, including mitochondrial encephalomyopathies and Leigh syndrome. Its dysfunction leads to decreased electron transport chain efficiency and excessive production of reactive oxygen species (ROS), making COXIV also an important potential target in research on ischemia-reperfusion injury, neurodegenerative diseases, and tumor metabolism.

  • 免疫印迹


    • WB result of COXIV Recombinant Mouse mAb
      Primary antibody: COXIV Recombinant Mouse mAb at 1/5000 dilution
      Lane 1: HeLa whole cell lysate 20 µg
      Lane 2: HepG2 whole cell lysate 20 µg
      Lane 3: A431 whole cell lysate 20 µg
      Lane 4: Jurkat whole cell lysate 20 µg
      Lane 5: MCF7 whole cell lysate 20 µg
      Lane 6: LnCap whole cell lysate 20 µg
      Secondary antibody: Goat Anti-Mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 20 kDa
      Observed MW: 17 kDa
    • WB result of COXIV Recombinant Mouse mAb
      Primary antibody: COXIV Recombinant Mouse mAb at 1/5000 dilution
      Lane 1: COS-7 whole cell lysate 20 µg
      Secondary antibody: Goat Anti-Mouse IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 20 kDa
      Observed MW: 17 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human cerebral cortex. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human kidney. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human liver. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human stomach. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human breast cancer. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human colon cancer. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human ovarian cancer. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human pancreatic cancer. Anti-COXIV antibody was used at 1/2000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

  • 组织表达图谱

    • Expression of COXIV in tumor tissues.

    • Expression of COXIV in human tissues.

评论(0)